Stay updated on JNJ-63723283 Combination with Daratumumab Clinical Trial

Sign up to get notified when there's something new on the JNJ-63723283 Combination with Daratumumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JNJ-63723283 Combination with Daratumumab Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Core content removal: the page no longer includes MedlinePlus Genetics topics on multiple myeloma, reducing coverage of that genetics-associated disease.
    Difference
    0.3%
    Check dated 2025-10-09T00:37:06.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    - Replaced term 'Plasma cell myeloma' with 'Multiple myeloma' in the core content. - Updated revision/version from v3.0.2 to v3.2.0.
    Difference
    0.2%
    Check dated 2025-10-01T03:13:03.000Z thumbnail image
  4. Check
    16 days ago
    Change Detected
    Summary
    Added a general term for the condition (Multiple myeloma) and updated version to v3.1.0; removed a MedlinePlus Genetics topic reference, the term Plasma cell myeloma, and the older version v3.0.2.
    Difference
    0.6%
    Check dated 2025-09-30T03:00:45.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Version updated to v3.0.2 with no substantive content changes; a minor 'Back to Top' navigation element was removed.
    Difference
    0.2%
    Check dated 2025-09-15T19:26:22.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-08T15:08:01.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility names and locations related to plasma cell myeloma, while also removing previous location terms and references to multiple myeloma.
    Difference
    2%
    Check dated 2025-09-01T09:43:41.000Z thumbnail image

Stay in the know with updates to JNJ-63723283 Combination with Daratumumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JNJ-63723283 Combination with Daratumumab Clinical Trial page.